Evidence map›Paper›PMID 42096810›Full record

ArticleJournal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)2026

Energy dispersive X-ray fluorescence provides a new option for measuring arsenic, mercury, and lead in dried blood spots.

Thomas R Grier, John F Obrycki, Marc G Weisskopf, Aaron J Specht

Abstract read
In one paragraph

Article in Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas R GrierSchool of Health Sciences, Purdue University, West Lafayette, IN 47906, United States.
John F ObryckiDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115, United States.
Marc G WeisskopfHarvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
Aaron J SpechtSchool of Health Sciences, Purdue University, West Lafayette, IN 47906, United States; Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States. Electronic address: aspecht@purdue.edu.

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6M
NIEHS NIH HHS P30 ES000002NIOSH CDC HHS K01 OH012528
6 · The paper itself

Abstract

backgroundEnergy-dispersive X-ray fluorescence (EDXRF) is a non-destructive analytical technique with potential for quantifying toxic metals in biological samples, but applications to dried blood spots (DBS) have largely focused on lead. The feasibility of simultaneous multi-element analysis in DBS using EDXRF has not been well established.

methodsWhole-blood NIST SRM 955c reference materials spanning four concentration levels were deposited onto protein saver cards at volumes ranging from 10 to 75 µL. Dried blood spots were analyzed using a benchtop EDXRF spectrometer for arsenic (As), mercury (Hg), and lead (Pb). Instrument response, blood spot volume effects, repeatability, detection limits, and limits of quantification were evaluated.

resultsBack-calculated XRF concentrations showed strong agreement with NIST-assigned values across the test concentration range for all three elements, with increased variability observed only at the lowest concentration level. Blood spot volume had no significant effect on measured concentrations for volumes ≥ 20 µL, while 10 µL spots exhibited increased variability. Repeatability improved with increasing concentration, with coefficients of variation decreasing from 16 to 53% at the lowest concentration level to ≤ 7% at the highest level. Detection limits were 2.3 µg/L for As, 3.6 µg/L for Hg, and 14.1 µg/L for Pb.

conclusionsEDXRF enables simultaneous measurement of As, Hg, and Pb in dried blood spots with analytical performance suitable for biomonitoring and exposure screening applications. This approach is particularly well suited for large-scale or retrospective studies requiring minimal sample preparation and non-destructive analysis.

Indexed as

ArsenicDried Blood Spot TestingLeadMercurySpectrometry, X-Ray EmissionHumansLimit of DetectionArsenicLeadMercuryDried Blood SpotsNIST 955cPotentially Toxic ElementsSurveillanceX-ray Fluorescence

Identifiers

PMID42096810
PMCPMC13361659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.